LIC reduces stake in Divi's laboratories through market sale

Life Insurance Corporation of India (LIC) has reported a reduction in its shareholding in Divi’s Laboratories Ltd., as disclosed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. LIC engaged in a market sale of shares between November 7, 2022, and January 16, 2025.

Before the sale, LIC held 13,360,663 shares, representing 5.033% of Divi’s Laboratories’ total share or voting capital. The market sale involved 5,354,352 shares, which accounted for 2.017% of the company’s capital.

Following this transaction, LIC’s holding in Divi’s Laboratories has decreased to 8,006,311 shares, equivalent to 3.016% of the total share or voting capital. The equity share capital and total voting capital of Divi’s Laboratories remain unchanged at 53,09,37,160.00 rupees both before and after the sale.